Ajay Kumar Duseja
Overview
Explore the profile of Ajay Kumar Duseja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Divyaveer S, Kashyap M, Kekan K, Premkumar M, Prajapati K, De A, et al.
Indian J Gastroenterol
. 2025 Mar;
PMID: 40053054
No abstract available.
2.
Dhiman B, Kundu R, Mitra S, Kalra N, Premkumar M, Duseja A, et al.
Cancer Cytopathol
. 2025 Mar;
133(4):e70009.
PMID: 40045688
Background: Hepatocellular carcinoma (HCC) may be diagnosed and further subclassified in surgical specimen as per the recent World Health Organization (WHO) classification into several distinct subtypes with prognostic implications. The...
3.
Premkumar M, Bhujade H, Sharma P, Nain J, Ahluwalia J, Sandhu A, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):971-987.
PMID: 39748673
Background And Aims: We assessed clinical, procoagulant and genetic risk factors and clinical outcomes in dabigatran-treated patients with non-tumoural acute and acute-on-chronic portal vein thrombosis (PVT). Methods: Patients with a...
4.
Premkumar M, Kajal K, Reddy K, Izzy M, Kulkarni A, Duseja A, et al.
Hepatology
. 2023 Nov;
79(5):1048-1064.
PMID: 37976391
Background And Aims: Treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI), with terlipressin and albumin, provides survival benefits, but may be associated with cardiopulmonary complications. We analyzed the predictors of terlipressin...
5.
Kajal K, Premkumar M, Izzy M, Kulkarni A, Duseja A, Divyaveer S, et al.
Aliment Pharmacol Ther
. 2023 Sep;
58(9):903-919.
PMID: 37688403
Background: Point-of-care echocardiography (POC-Echo) is an essential intensive care hemodynamic monitoring tool. Aims: To assess POC-Echo parameters [i.e., cardiac index (CI), systemic vascular resistance index (SVRI) and cirrhotic cardiomyopathy (CCM)...
6.
Kaur B, Dixit R, Bakshi S, Konar M, Sinha S, Duseja A, et al.
Sci Rep
. 2023 Jun;
13(1):10135.
PMID: 37349331
Traditional markers evaluate anti-tubercular drug-induced liver injury (AT-DILI). However, these markers have certain limitations and studies are in progress to characterize AT-DILI at an early stage. In the present study,...
7.
Maiwall R, Pasupuleti S, Choudhury A, Kim D, Sood A, Goyal O, et al.
Hepatol Int
. 2022 Dec;
17(3):662-675.
PMID: 36571711
Background And Aim: Acute-on-chronic liver failure (ACLF) is a severe form of alcoholic hepatitis (SAH). We aimed to study the natural course, response to corticosteroids (CS), and the role of...
8.
Premkumar M, Mehtani R, Kulkarni A, Duseja A, De A, Taneja S, et al.
Dig Dis Sci
. 2022 Aug;
68(2):497-513.
PMID: 35984611
Background: Hyperfibrinolysis and coagulation dysfunction may occur in cirrhotic patients with acute variceal bleed (AVB) despite successful endotherapy. Aims: To prospectively study the association of endogenous heparinoids and coagulation dysfunction...
9.
Kaur H, Dhiman R, Kulkarni A, Premkumar M, Singh V, Duseja A, et al.
J Viral Hepat
. 2022 Mar;
29(5):395-406.
PMID: 35266624
Chronic hepatitis C virus (HCV) infection is associated with neuropsychiatric changes. Also, patients with cirrhosis may develop overt or minimal hepatic encephalopathy. Sustained virological response (SVR) with direct-acting antiviral agents...
10.
Sharma K, Gupta N, Goyal K, Duseja A, Sharma A, Rajwanshi A
Cytojournal
. 2017 Feb;
14:1.
PMID: 28217140
Background: Tubercular involvement of the liver is uncommon, but is a serious consideration in differential diagnosis of granulomatous conditions, especially in endemic regions like India. Objective: To assess the role...